Facebook tracking pixel
J86.9
ICD-10-CM
Empyema

Learn about empyema (pyothorax), a collection of pus in the pleural space. This guide covers diagnosis, pleural empyema treatment, ICD-10 coding, clinical documentation best practices, and healthcare insights for medical professionals. Find information on symptoms, causes, and management of this serious condition.

Also known as

Pyothorax
Pleural empyema

Diagnosis Snapshot

Key Facts
  • Definition : Pus collection within the pleural space surrounding the lungs.
  • Clinical Signs : Chest pain, fever, cough, shortness of breath, fatigue.
  • Common Settings : Hospitalized patients, post-pneumonia, thoracic surgery.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC J86.9 Coding
J86.0

Pyothorax with fistula

Pus in the pleural cavity with an abnormal connection.

J86.9

Empyema, unspecified

Pus in the pleural cavity without further specification.

J90

Pleural effusion in other conditions

Fluid buildup in the pleural cavity associated with other conditions, which can include empyema.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the empyema related to tuberculosis?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Pus in the pleural space.
Fluid in the pleural space.
Blood in the pleural space.

Documentation Best Practices

Documentation Checklist
  • Empyema documentation: laterality (left/right)
  • Thoracentesis findings, pus characteristics
  • Document causative organism if identified
  • Imaging evidence supporting empyema diagnosis
  • ICD-10-CM code J86.0, Pyothorax or J86.9, Pleural empyema NOS

Coding and Audit Risks

Common Risks
  • Unspecified Empyema

    Coding empyema without laterality (left/right) or organism specification can lead to claim denials and inaccurate severity reflection.

  • Empyema vs. Complicated Pneumonia

    Miscoding complicated pneumonia with pleural effusion as empyema, or vice-versa, impacts DRG assignment and reimbursement.

  • Missing Post-procedural Diagnosis

    If empyema develops post-procedure, failing to code the causal relationship may affect quality reporting and complication tracking.

Mitigation Tips

Best Practices
  • Thorough documentation of empyema stage for accurate ICD-10 coding (J86.0).
  • Document source and cause of pyothorax for proper CDI and billing.
  • Timely pleural fluid cultures improve diagnosis and guide antibiotic therapy.
  • Image-guided drainage crucial, document procedure and findings for compliance.
  • Regular monitoring, antibiotic stewardship, and follow-up care essential.

Clinical Decision Support

Checklist
  • Verify pleural fluid purulence or bacteria presence (ICD-10 J86.0)
  • Confirm via chest imaging: CXR, CT scan (CPT 71010, 71250)
  • Document patient symptoms: fever, cough, chest pain (SNOMED CT)
  • Consider thoracentesis for diagnostic sampling (CPT 32554)

Reimbursement and Quality Metrics

Impact Summary
  • Empyema (Pyothorax) reimbursement hinges on accurate ICD-10 coding (J86.0, J86.9) and supporting documentation for medical necessity.
  • Thoracic surgery, drainage procedures, and antibiotic therapy impact Empyema DRG assignment and hospital payment.
  • Quality metrics for Empyema track infection control, treatment efficacy, and patient outcomes (e.g., length of stay, readmission rates).
  • Coding validation and clinical documentation improvement programs enhance Empyema reimbursement and reporting accuracy.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Frequently Asked Questions

Common Questions and Answers

Q: What are the best practices for diagnosing empyema (pyothorax) complicated by loculated pleural effusions in critically ill patients?

A: Diagnosing empyema, particularly when complicated by loculated pleural effusions, in critically ill patients requires a multi-pronged approach. Chest radiography may reveal pleural fluid, but often lacks sensitivity for loculations. Ultrasound is crucial for identifying septations, guiding thoracentesis, and differentiating between simple effusions and complex collections suggestive of empyema. Contrast-enhanced CT scans are essential for characterizing the extent of loculations, detecting underlying lung pathologies, and guiding drainage procedures. Thoracentesis with pleural fluid analysis is key, including assessment of pH, glucose, LDH, cell count and differential, Gram stain, and culture. In complex cases, especially in ventilated patients, consider exploring advanced imaging techniques like intrapleural fibrinolytic therapy or video-assisted thoracoscopic surgery (VATS) to optimize drainage and manage the empyema effectively. Explore how ultrasound-guided thoracentesis can improve diagnostic accuracy in critically ill patients.

Q: How do I differentiate between uncomplicated parapneumonic effusion, complicated parapneumonic effusion, and empyema (pyothorax) based on pleural fluid analysis and imaging findings?

A: Differentiating between uncomplicated, complicated parapneumonic effusions, and empyema relies on a combination of pleural fluid analysis and imaging findings. Uncomplicated parapneumonic effusions typically show a low pH (>7.2), glucose >60 mg/dL, LDH <1000 IU/L, and negative Gram stain and cultures. Imaging often reveals a simple effusion. Complicated parapneumonic effusions demonstrate a lower pH (<7.2), lower glucose, elevated LDH, and may have positive cultures. Ultrasound may show some loculations. Empyema is characterized by frankly purulent fluid, a significantly low pH (<7.0), very low glucose, and positive cultures. Imaging, especially CT, reveals thick pleural peel, septations, and often loculated collections. Consider implementing a standardized pleural fluid analysis protocol to ensure consistent and accurate differentiation between these conditions. Learn more about the role of pH and glucose in pleural fluid analysis.

Quick Tips

Practical Coding Tips
  • Code J86.0 for empyema
  • Document pus location
  • Query physician for cause
  • Check for organism, code if known
  • Consider ICD-10 laterality

Documentation Templates

Patient presents with signs and symptoms consistent with empyema, also known as pyothorax or pleural empyema.  Clinical findings include [insert specific findings e.g., fever, chills, productive cough with purulent sputum, pleuritic chest pain, dyspnea].  Physical examination revealed [insert specific findings e.g., decreased breath sounds, dullness to percussion, egophony, tactile fremitus].  The patient's medical history includes [list relevant medical history e.g., recent pneumonia, thoracic surgery, trauma].  Differential diagnoses considered include pneumonia, lung abscess, and malignant pleural effusion.  Chest imaging, specifically a chest x-ray and or CT scan of the chest, demonstrated [describe imaging findings e.g., loculated pleural effusion, pleural thickening].  Thoracentesis was performed, and pleural fluid analysis revealed [describe pleural fluid analysis results e.g., turbid fluid, positive gram stain, elevated white blood cell count, low glucose, low pH consistent with empyema].  Based on these findings, a diagnosis of empyema was established.  Treatment plan includes antibiotic therapy with [specify antibiotic regimen] and drainage of the pleural fluid collection via [specify drainage method e.g., chest tube insertion, thoracoscopic drainage, open thoracotomy].  Patient education regarding empyema management, potential complications, and follow-up care was provided.  ICD-10 code J86.0 (pyothorax with fistula) or J86.9 (pyothorax without fistula) is appropriate, depending on the presence or absence of a fistula.  CPT codes for the procedures performed, such as thoracentesis (32554, 32555) or chest tube placement (32551, 32556), will be used for billing purposes.  The prognosis for resolution of the empyema depends on the underlying cause and the patient's overall health status.  Close monitoring and follow-up are essential to ensure adequate treatment response and to address any potential complications, including sepsis, respiratory failure, and long-term pulmonary dysfunction.